Advertisement

Anti-inflammatory and anti-atherogenic effects of cathechin, caffeic acid and trans-resveratrol in apolipoprotein E deficient mice

      Abstract

      A strong negative correlation between polyphenols consumption and coronary heart disease has been extensively documented. These results prompted investigations on the mechanisms responsible for polyphenols effects in cardiovascular disease.
      The aim of this work was to investigate in apoE KO mice the effect of P183/1 (a mixture of cathechin, caffeic acid and resveratrol) on atherosclerosis and gene expression patterns in the vascular wall.
      ApoE KO mice were fed a diet supplemented with P183/1, 40 and 160 mg/kg body weight/day for 8 weeks. The supplementation with the high dose of P183/1 significantly reduced the presence of atherosclerotic plaque by 40 and 36% in the aortic sinus and in the ascending aorta, respectively. This reduction was associated with a reduced expression of markers for macrophages, lymphocytes (both Th1 and Th2) and of MCP-1, MIP-1α, MIP-1β, CCR1, CCR2 and ET1 in the vascular wall. In conclusion, P183/1 supplementation significantly decreases atherosclerosis in ApoE KO mice by affecting inflammatory cells recruitment and expression of pro-inflammatory chemokines in the vascular wall.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Atherosclerosis
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Manach C.
        • Mazur A.
        • Scalbert A.
        Polyphenols and prevention of cardiovascular diseases.
        Curr Opin Lipidol. 2005; 16: 77-84
        • Stoclet J.C.
        • Chataigneau T.
        • Ndiaye M.
        • et al.
        Vascular protection by dietary polyphenols.
        Eur J Pharmacol. 2004; 500: 299-313
        • Hayek T.
        • Fuhrman B.
        • Vaya J.
        • et al.
        Reduced progression of atherosclerosis in apolipoprotein E-deficient mice following consumption of red wine, or its polyphenols quercetin or catechin, is associated with reduced susceptibility of LDL to oxidation and aggregation.
        Arterioscler Thromb Vasc Biol. 1997; 17: 2744-2752
        • Vinson J.A.
        • Teufel K.
        • Wu N.
        Green and black teas inhibit atherosclerosis by lipid, antioxidant, and fibrinolytic mechanisms.
        J Agric Food Chem. 2004; 52: 3661-3665
        • Vinson J.A.
        • Teufel K.
        • Wu N.
        Red wine, dealcoholized red wine, and especially grape juice, inhibit atherosclerosis in a hamster model.
        Atherosclerosis. 2001; 156: 67-72
        • Miura Y.
        • Chiba T.
        • Tomita I.
        • et al.
        Tea catechins prevent the development of atherosclerosis in apoprotein E-deficient mice.
        J Nutr. 2001; 131: 27-32
        • Waddington E.
        • Puddey I.B.
        • Croft K.D.
        Red wine polyphenolic compounds inhibit atherosclerosis in apolipoprotein E-deficient mice independently of effects on lipid peroxidation.
        Am J Clin Nutr. 2004; 79: 54-61
        • Chyu K.Y.
        • Babbidge S.M.
        • Zhao X.
        • et al.
        Differential effects of green tea-derived catechin on developing versus established atherosclerosis in apolipoprotein E-null mice.
        Circulation. 2004; 109: 2448-2453
      1. Pignatelli P, Ghiselli A, Buchetti B, et al. Polyphenols synergistically inhibit oxidative stress in subjects given red and white wine. Atherosclerosis, in press.

        • Norata G.D.
        • Callegari E.
        • Marchesi M.
        • et al.
        High-density lipoproteins induce transforming growth factor-beta2 expression in endothelial cells.
        Circulation. 2005; 111: 2805-2811
        • Norata G.D.
        • Callegari E.
        • Inoue H.
        • Catapano A.L.
        HDL3 induces cyclooxygenase-2 expression and prostacyclin release in human endothelial cells via a p38 MAPK/CRE-dependent pathway: effects on COX-2/PGI-synthase coupling.
        Arterioscler Thromb Vasc Biol. 2004; 24: 871-877
        • Norata G.D.
        • Tibolla G.
        • Seccomandi P.M.
        • Poletti A.
        • Catapano A.L.
        Dihydrotestosterone decreases tumor necrosis factor-alpha and lipopolysaccharide-induced inflammatory response in human endothelial cells.
        J Clin Endocrinol Metab. 2006; 91: 546-554
        • Libby P.
        Inflammation in atherosclerosis.
        Nature. 2002; 420: 868-874
        • Hansson G.K.
        Inflammation, atherosclerosis, and coronary artery disease.
        N Engl J Med. 2005; 352: 1685-1695
        • Ferrero M.E.
        • Bertelli A.E.
        • Fulgenzi A.
        • et al.
        Activity in vitro of resveratrol on granulocyte and monocyte adhesion to endothelium.
        Am J Clin Nutr. 1998; 68: 1208-1214
        • Pellegatta F.
        • Bertelli A.A.
        • Staels B.
        • et al.
        Different short- and long-term effects of resveratrol on nuclear factor-kappaB phosphorylation and nuclear appearance in human endothelial cells.
        Am J Clin Nutr. 2003; 77: 1220-1228
        • Koga T.
        • Meydani M.
        Effect of plasma metabolites of (+)-catechin and quercetin on monocyte adhesion to human aortic endothelial cells.
        Am J Clin Nutr. 2001; 73: 941-948
        • Veillard N.R.
        • Steffens S.
        • Burger F.
        • Pelli G.
        • Mach F.
        Differential expression patterns of proinflammatory and antiinflammatory mediators during atherogenesis in mice.
        Arterioscler Thromb Vasc Biol. 2004; 24: 2339-2344
        • Charo I.F.
        • Taubman M.B.
        Chemokines in the pathogenesis of vascular disease.
        Circ Res. 2004; 95: 858-866
        • Flesch M.
        • Schwarz A.
        • Bohm M.
        Effects of red and white wine on endothelium-dependent vasorelaxation of rat aorta and human coronary arteries.
        Am J Physiol. 1998; 275: H1183-H1190
        • Wallerath T.
        • Poleo D.
        • Li H.
        • Forstermann U.
        Red wine increases the expression of human endothelial nitric oxide synthase: a mechanism that may contribute to its beneficial cardiovascular effects.
        J Am Coll Cardiol. 2003; 41: 471-478
        • Fitzpatrick D.F.
        • Hirschfield S.L.
        • Coffey R.G.
        Endothelium-dependent vasorelaxing activity of wine and other grape products.
        Am J Physiol. 1993; 265: H774-H778
        • Achike F.I.
        • Kwan C.Y.
        Nitric oxide, human diseases and the herbal products that affect the nitric oxide signalling pathway.
        Clin Exp Pharmacol Physiol. 2003; 30: 605-615
        • Liu J.C.
        • Chen J.J.
        • Chan P.
        • Cheng C.F.
        • Cheng T.H.
        Inhibition of cyclic strain-induced endothelin-1 gene expression by resveratrol.
        Hypertension. 2003; 42: 1198-1205
        • Corder R.
        • Douthwaite J.A.
        • Lees D.M.
        • et al.
        Endothelin-1 synthesis reduced by red wine.
        Nature. 2001; 414: 863-864
        • Oak M.H.
        • Chataigneau M.
        • Keravis T.
        • et al.
        Red wine polyphenolic compounds inhibit vascular endothelial growth factor expression in vascular smooth muscle cells by preventing the activation of the p38 mitogen-activated protein kinase pathway.
        Arterioscler Thromb Vasc Biol. 2003; 23: 1001-1007
        • Kronemann N.
        • Bouloumi A.
        • Bassus S.
        • et al.
        Aggregating human platelets stimulate expression of vascular endothelial growth factor in cultured vascular smooth muscle cells through a synergistic effect of transforming growth factor-beta(1) and platelet-derived growth factor(AB).
        Circulation. 1999; 100: 855-860
        • Moulton K.S.
        • Vakili K.
        • Zurakowski D.
        • et al.
        Inhibition of plaque neovascularization reduces macrophage accumulation and progression of advanced atherosclerosis.
        Proc Natl Acad Sci USA. 2003; 100: 4736-4741